Aprea Therapeutics (APRE) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, with all directors and the independent auditor present virtually.

• Virtual format enabled broader stockholder participation and engagement.

• Agenda included director elections, auditor ratification, reverse stock split, executive compensation, say-on-pay frequency, and potential adjournment.

Board and executive committee updates

• Three current directors nominated for re-election to serve until the 2029 annual meeting.

• All directors attended virtually, and the independent auditor was available for questions.

Shareholder proposals

• Proposals included director elections, auditor ratification, reverse stock split authorization, executive compensation approval, say-on-pay frequency, and adjournment if needed.